DK1906961T3 - Fast doserede formuleringer af fentanyl med forbedret bukkal adsorption - Google Patents
Fast doserede formuleringer af fentanyl med forbedret bukkal adsorption Download PDFInfo
- Publication number
- DK1906961T3 DK1906961T3 DK06776336.7T DK06776336T DK1906961T3 DK 1906961 T3 DK1906961 T3 DK 1906961T3 DK 06776336 T DK06776336 T DK 06776336T DK 1906961 T3 DK1906961 T3 DK 1906961T3
- Authority
- DK
- Denmark
- Prior art keywords
- fentanyl
- amine
- active ingredient
- adsorption
- buchal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (4)
1. Farmaceutisk sammensætning i form af en tablet der er egnet til opløsning i mundhulen, hvilken sammensætning omfatter i) en effektiv mængde afen narkotisk aktiv bestanddel valgt fra gruppen bestående af Fentanyl og farmaceutisk acceptable salte deraf, og ii) en farmaceutisk acceptabel amin med en pK på 8 eller derover, hvor aminen er arginin, hvor molforholdet af amin:aktiv bestanddel er mindst 5:1.
2. Sammensætningen ifølge krav 1, hvor molforholdet af amin:aktiv bestanddel er fra 5:1 til 1000:1.
3. Sammensætningen ifølge krav 2, hvor molforholdet af amin: aktiv bestanddel ligger i området fra 10:1 til 500:1.
4. Sammensætningen ifølge krav 3, hvor molforholdet af amin:aktiv bestanddel ligger i området fra 20:1 til 250:1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/186,925 US20070020186A1 (en) | 2005-07-22 | 2005-07-22 | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
PCT/EP2006/007189 WO2007009806A2 (en) | 2005-07-22 | 2006-07-21 | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1906961T3 true DK1906961T3 (da) | 2016-05-02 |
Family
ID=37440618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06776336.7T DK1906961T3 (da) | 2005-07-22 | 2006-07-21 | Fast doserede formuleringer af fentanyl med forbedret bukkal adsorption |
Country Status (26)
Country | Link |
---|---|
US (3) | US20070020186A1 (da) |
EP (1) | EP1906961B1 (da) |
JP (1) | JP5714797B2 (da) |
KR (1) | KR101326206B1 (da) |
CN (1) | CN101208091A (da) |
AU (1) | AU2006271870B2 (da) |
BR (1) | BRPI0613769A2 (da) |
CA (1) | CA2607360C (da) |
CY (1) | CY1117470T1 (da) |
DK (1) | DK1906961T3 (da) |
ES (1) | ES2569228T3 (da) |
HR (1) | HRP20160327T1 (da) |
HU (1) | HUE027354T2 (da) |
IL (1) | IL187387A (da) |
MA (1) | MA29744B1 (da) |
MX (1) | MX2007015480A (da) |
NO (1) | NO20080827L (da) |
NZ (1) | NZ563511A (da) |
PL (1) | PL1906961T3 (da) |
RS (1) | RS54670B1 (da) |
RU (1) | RU2408373C2 (da) |
SI (1) | SI1906961T1 (da) |
TW (1) | TW200727922A (da) |
UA (1) | UA90518C2 (da) |
WO (1) | WO2007009806A2 (da) |
ZA (1) | ZA200710406B (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US9289583B2 (en) * | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US20070260491A1 (en) * | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
BRPI0811319A2 (pt) | 2007-05-25 | 2015-02-10 | Tolmar Therapeutics Inc | Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
EP2440210A4 (en) | 2009-06-12 | 2014-01-29 | Meritage Pharma Inc | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES |
GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
RU2476209C1 (ru) * | 2012-02-29 | 2013-02-27 | Станислав Анатольевич Кедик | Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов |
ES2699806T3 (es) | 2012-04-18 | 2019-02-12 | SpecGx LLC | Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata |
PL2872121T3 (pl) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
SG11201704797TA (en) | 2014-12-23 | 2017-07-28 | Acelrx Pharmaceuticals Inc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
EP3856160A4 (en) | 2018-09-25 | 2022-07-06 | SpecGx LLC | ANTI-ABUSE IMMEDIATE RELEASE CAPSULES DOSAGE FORMS |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785989A (en) * | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
JP3069458B2 (ja) * | 1992-01-29 | 2000-07-24 | 武田薬品工業株式会社 | 口腔内崩壊型錠剤およびその製造法 |
US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
US5624677A (en) * | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5888534A (en) * | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
WO1998002186A1 (en) * | 1996-07-11 | 1998-01-22 | Farmarc Nederland B.V. | Inclusion complex containing indole selective serotonin agonist |
JP3770666B2 (ja) | 1996-09-20 | 2006-04-26 | 株式会社ティ・ティ・エス技術研究所 | 経粘膜吸収製剤用組成物 |
EP0839526A3 (en) * | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
JP4947833B2 (ja) * | 1997-07-25 | 2012-06-06 | アルペックス・ファルマ・ソシエテ・アノニム | 速崩壊性口内溶解錠の製造に適した顆粒の製造方法 |
US5869098A (en) * | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
US6680071B1 (en) * | 1999-03-03 | 2004-01-20 | R. P. Scherer Technologies, Inc. | Opioid agonist in a fast dispersing dosage form |
JP2000281589A (ja) * | 1999-03-26 | 2000-10-10 | T T S Gijutsu Kenkyusho:Kk | 経粘膜吸収助剤 |
US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
JP2005526095A (ja) * | 2002-03-20 | 2005-09-02 | エラン ファーマ インターナショナル,リミティド | 脆砕性の低い急速溶解投与剤型 |
EP1495026A4 (en) * | 2002-03-20 | 2008-07-09 | Univ Queensland | METHODS AND COMPOSITIONS CONTAINING NITRIC OXIDE DONORS AND OPIOID ANALGESICS |
US20040253307A1 (en) * | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
US20040202698A1 (en) * | 2003-04-02 | 2004-10-14 | The Procter & Gamble Company | Drug delivery systems comprising an encapsulated active ingredient |
US7749533B2 (en) * | 2003-05-07 | 2010-07-06 | Akina, Inc. | Highly plastic granules for making fast melting tablets |
NZ548216A (en) * | 2003-12-31 | 2010-02-26 | Cima Labs Inc | Generally linear effervescent oral fentanyl dosage form and methods of administering |
-
2005
- 2005-07-22 US US11/186,925 patent/US20070020186A1/en not_active Abandoned
-
2006
- 2006-07-21 CA CA2607360A patent/CA2607360C/en active Active
- 2006-07-21 EP EP06776336.7A patent/EP1906961B1/en active Active
- 2006-07-21 BR BRPI0613769-5A patent/BRPI0613769A2/pt not_active Application Discontinuation
- 2006-07-21 KR KR1020087000576A patent/KR101326206B1/ko active IP Right Grant
- 2006-07-21 HU HUE06776336A patent/HUE027354T2/en unknown
- 2006-07-21 NZ NZ563511A patent/NZ563511A/en not_active IP Right Cessation
- 2006-07-21 UA UAA200713973A patent/UA90518C2/ru unknown
- 2006-07-21 RU RU2007149044/15A patent/RU2408373C2/ru active
- 2006-07-21 AU AU2006271870A patent/AU2006271870B2/en not_active Ceased
- 2006-07-21 ES ES06776336.7T patent/ES2569228T3/es active Active
- 2006-07-21 SI SI200632040A patent/SI1906961T1/sl unknown
- 2006-07-21 JP JP2008521904A patent/JP5714797B2/ja active Active
- 2006-07-21 WO PCT/EP2006/007189 patent/WO2007009806A2/en active Application Filing
- 2006-07-21 CN CNA2006800232888A patent/CN101208091A/zh active Pending
- 2006-07-21 RS RS20160214A patent/RS54670B1/en unknown
- 2006-07-21 DK DK06776336.7T patent/DK1906961T3/da active
- 2006-07-21 PL PL06776336T patent/PL1906961T3/pl unknown
- 2006-07-21 TW TW095126670A patent/TW200727922A/zh unknown
- 2006-07-21 US US11/490,500 patent/US8574552B2/en active Active
- 2006-07-21 MX MX2007015480A patent/MX2007015480A/es active IP Right Grant
-
2007
- 2007-11-15 IL IL187387A patent/IL187387A/en not_active IP Right Cessation
- 2007-11-30 ZA ZA200710406A patent/ZA200710406B/xx unknown
-
2008
- 2008-02-15 NO NO20080827A patent/NO20080827L/no not_active Application Discontinuation
- 2008-02-18 MA MA30659A patent/MA29744B1/fr unknown
-
2013
- 2013-09-04 US US14/017,642 patent/US10258693B2/en active Active
-
2016
- 2016-04-01 HR HRP20160327TT patent/HRP20160327T1/hr unknown
- 2016-04-26 CY CY20161100346T patent/CY1117470T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1906961T3 (da) | Fast doserede formuleringer af fentanyl med forbedret bukkal adsorption | |
ES2167921T5 (es) | Comprimido multiparticulado perfeccionado de disgregación rápida | |
ES2336943T3 (es) | Comprimido de bosentan dispersable. | |
JP2007507548A (ja) | 速崩壊型製剤 | |
ES2384333T3 (es) | Composiciones farmacéuticas que tienen perfiles de disolución mejorados para fármacos poco solubles | |
JP2008285434A (ja) | 口腔内速崩壊錠 | |
JP2010270110A (ja) | ネオテームを含有する経口製剤 | |
KR20150002453A (ko) | 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제 | |
KR102051132B1 (ko) | 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 | |
JP5168712B2 (ja) | ナテグリニド含有製剤 | |
ES2288117B1 (es) | Composicion farmaceutica solida de gabapentina. | |
US10016359B2 (en) | Solid forms containing meloxicam with improved buccal taste and process for their preparation | |
Kumar et al. | Development and characterization of melt-in-mouth tablets of haloperidol by sublimation technique | |
KR100752417B1 (ko) | 안정성이 증진된, 마진돌을 포함하는 약제학적 조성물 | |
JP6538321B2 (ja) | 経口組成物 | |
KR100435514B1 (ko) | 실데나필 젖산염의 속효제형 | |
KR101244627B1 (ko) | 올란자핀을 함유하는 확산정 조성물 및 이에 의해 형성된 정제 | |
KR101779513B1 (ko) | 애엽의 이소프로판올 추출물을 포함하는 약제학적 조성물 | |
ES2960207T3 (es) | Combinación de dosis fijas de liberación inmediata de memantina y donepezilo | |
EP4183390A1 (en) | An orodispersible pharmaceutical dosage form of edoxaban | |
KR20220057077A (ko) | 타다라필을 포함하는 구강붕해 필름 제형 | |
KR20170001668A (ko) | 애엽의 이소프로판올 추출물을 포함하는 약제학적 조성물 | |
More et al. | Chapter-4 Formulation and Comparative Evaluation of Sublingual Tablets of Ondansetron Hydrochloride | |
NZ243613A (en) | Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations | |
JP2001131068A (ja) | エナラプリル塩を安定化した製剤及びその方法 |